Venus Concept Inc. (VERO)
undefined
undefined%
At close: undefined

Company Description

Venus Concept Inc., a medical technology company, develops, commercializes, and delivers minimally invasive and non-invasive medical aesthetic and hair restoration technologies, and related services in the United States and internationally.

Its product portfolio includes aesthetic device platforms, including Venus Legacy, a noninvasive device used in dermatological and general surgical procedures for females; Venus Versa, a multi-application device used in aesthetic and cosmetic procedures; and Venus Viva, an advanced, portable, and fractional RF system for dermatological procedures requiring ablation and resurfacing of the skin.

The company also offers Venus Fiore, a device that delivers non-thermal RF with massage and magnetic field pulses to treat various medical conditions; Venus Bliss, a device for non-invasive lipolysis of the abdomen and flanks in individuals with a body mass index of 30 or less; Venus Glow, a dermabrasion device used to improve skin appearance; and NeoGraft, an advanced hair restoration technology with an automated FUE and implantation system.

In addition, it provides Venus Velocity and Venus Epileve for hair removal, permanent hair reduction, and treatment of pseudofolliculitis barbae; and ARTAS iX, a robotic system to assist physicians in identifying and extracting hair follicles units from the scalp during hair transplantation, creating recipient sites, and implanting the harvested hair follicles.

The company is headquartered in Toronto, Canada.

Venus Concept Inc.
Venus Concept Inc. logo
Country CA
IPO Date Oct 12, 2017
Industry Medical - Devices
Sector Healthcare
Employees 304
CEO Rajiv Kanishka Liyanaarchchie De Silva

Contact Details

Address:
235 Yorkland Boulevard
Toronto, ON
CA
Website https://www.venusconcept.com

Stock Details

Ticker Symbol VERO
Exchange NASDAQ
Fiscal Year January - December
Reporting Currency USD
CIK Code 0001409269
CUSIP Number 92332W105
ISIN Number US92332W2044
Employer ID 06-1681204
SIC Code 3841

Key Executives

Name Position
Rajiv Kanishka Liyanaarchchie De Silva Chief Executive Officer & Director
Dr. Hemanth Jacob Varghese CFA, Ph.D. President & Chief Operating Officer
Anat Kotler Head of Marketing & Product Management
Anna Georgiadis Chief Human Resources Officer
Dr. Yoni Iger Head of Scientific & Clinical Affairs
Joyce Morris Head of Sales - Canada
Michael Mandarello General Counsel & Corporate Secretary
Ognjen Petrovic Head of R&D, Robotics, Software
Ross J. Portaro Executive Vice President and GM of Global Sales & Marketing
William H. McGrail Executive Vice President of Technical Operations & Compliance

Latest SEC Filings

Date Type Title
Dec 04, 2024 4 Filing
Dec 03, 2024 8-K Current Report
Nov 13, 2024 10-Q Quarterly Report
Nov 13, 2024 8-K Current Report
Nov 04, 2024 8-K Current Report
Oct 24, 2024 S-3 Filing
Oct 08, 2024 SC 13D/A [Amend] Filing
Oct 03, 2024 SC 13D/A [Amend] Filing
Oct 02, 2024 4 Filing
Sep 30, 2024 SC 13G/A [Amend] Statement of acquisition of beneficial own...